The trial is unlikely to show a statistically significant improvement in invasive disease-free survival

The vaccine could be Janssen’s first to win EU approval

Breast cancer is the most common cancer in women. But individual tumors can vary significantly, presenting different spatial […]

The ongoing COVID-19 pandemic has severely impacted the manufacturing and supply chains for many products. But while shortages […]

ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab? chelfand Sun, 05/31/2020 – 16:58

ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data chelfand Sun, 05/31/2020 – 14:03

Pfizer’s Ibrance misses shot at big new market with early breast cancer failure chelfand Sat, 05/30/2020 – 17:46

Updated Date: Fri, 22 May 2020 00:00:00 EDT

Updated Date: Fri, 22 May 2020 00:00:00 EDT

Updated Date: Fri, 22 May 2020 00:00:00 EDT